TNF, tumor necrosis factor, 7124

N. diseases: 2724; N. variants: 31
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE Kaempferol reduced CD3<sup>+</sup> T cell infiltration and gene expression of major proinflammatory cytokines, including interleukin (IL)-6, IL-17A and tumor necrosis factor (TNF)-α, in the psoriatic skin lesion. 31407330 2019
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE The purpose of this study was to investigate the anti-atopic effects of UMB on 2,4-dinitrochlorobenzene (DNCB)- and house dust mite extract (Dermatophagoides farinae extract, DFE)-treated mice with AD-like skin lesions and on tumor necrosis factor (TNF)-α/interferon (IFN)-γ-treated HaCaT cells. 31437788 2019
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 AlteredExpression group BEFREE The following were assessed: dermatitis severity scores; ear and dorsal skin haematoxylin and eosin staining; interleukin (IL)- 1α, IL-1β, IL-2, IL-4, IL-6, and tumour necrosis factor (TNF)-α cytokine levels in the serum; spleen index; spleen CD4 + /CD8 + T lymphocyte ratio; and phosphorylation levels of mitogen-activated protein kinases (MAPKs- p38, extracellular signal-regulated kinase (ERK), and c-Jun N-terminal kinase (JNK)), IκB-α, and nuclear factor (NF)-κB (p65) in skin lesions. 29698775 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE Expression of TNF-α in palmoplantar pustulosis increased after anti-TNF-α therapy in the two examined patients with exacerbated skin lesions. 29611085 2019
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE Importantly, Tnf gene deficiency prevented skin lesions in cpdm mice. 21455173 2011
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 AlteredExpression group BEFREE The mRNA and protein expression levels in human and mouse skin lesions and TNF‑α‑stimulated HaCaT cells were detected using reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blotting, and compared with the control groups. 31017270 2019
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE Treatment of K5.Stat3C mice with TNF-α or EGFR inhibitors attenuated the skin lesions, suggesting the roles of TACE substrates in psoriasis. 25384035 2014
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 AlteredExpression group BEFREE In addition, Cal/BDP significantly suppressed the interleukin (IL)-23/IL-17-producing T (T17) pathogenic axis, including expression of IL-17a, IL-23a, IL-22 and TNF-α mRNA in skin lesions and expansion of CCR6<sup>+</sup> γδ T17 cells in the draining lymph nodes. 31705000 2019
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE This study has the aim to identify early critical events for the resolution of inflammation in skin lesions using anti-TNF therapy. 23731727 2013
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 AlteredExpression group BEFREE We first found that IL-1β and TNF-α mRNA expression was significantly decreased in the skin lesions treated with DDH-1. 30503675 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE It was found that genistein can significantly improve IMQ-induced pathological scores of cutaneous skin lesions in mice, reduce epidermal thickness, and inhibit the expression of inflammatory factors,including interleukin (IL)-1β, IL-6, tumour necrosis factor-alpha (TNF-α), chemokine ligand 2 (CCL2), IL-17 and IL-23. 30743203 2019
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 AlteredExpression group BEFREE Macroscopic and microscopic evaluation of skin lesions was performed together with measurements of serum levels of interleukin (IL)-1β, IL-6, tumour necrosis factor alpha (TNF-α), IL-17, IL-22, IL-10 and IL-4. 29409331 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 AlteredExpression group BEFREE Administration of CK onto DNCB-induced AD-like skin lesions in NC/Nga mice ameliorated lesion intensity scores, levels of IgE, thymus and activation-regulated chemokine (TARC), TNF-α, and IL-4 in serum and ears. 22407167 2012
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 AlteredExpression group BEFREE Lesion size reduction was associated with reduced expression of IRS-1 (P < 0.01), TNFα (P < 0.0001), and vascular endothelial growth factor (P < 0.01); reduced keratinocyte proliferation (P < 0.01); and the restoration (P < 0.02) of normal levels of infiltrating CD4(+) and CD3(+) lymphocytes in psoriatic skin lesions. 24504098 2014
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE After 1 year's treatment, the skin lesions exhibited a reduction in granulomas, and a concomitant reduction in deposits of TNF-alpha. 9115924 1997
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE Oral administration of L. chungangensis CAU 28(T) suppressed the production of IL-4, IL-5, IL-12, IFN-γ, tumor necrosis factor-α, and thymus- and activation-regulated chemokine (TARC) in skin lesions, indicating that it strongly drives the local immune system with efficacy comparable to that of tacrolimus, a topical immunomodulatory drug used for the treatment of atopic dermatitis. 27289147 2016
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE CRT effectively mitigated the secretion of pro‑inflammatory cytokines, including tumor necrosis factor‑α and interleukin 1β, as well as immune cell infiltration into skin lesions in a mouse model of AD‑like skin disease induced by dinitrochlorobenzene. 29845271 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 AlteredExpression group BEFREE SP treatment significantly reduced the infiltration of mast cells and CD3-positive T cells as well as inflammatory cytokines, such as tumor necrosis factor-α (TNF-α) and thymic stromal lymphopoietin (TSLP), in AD-like skin lesions and decreased the levels of IgE and thymus and activation-regulated chemokine in serum. 28833499 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE After 1 month of prednisolone treatment the sizes of the skin granulomas were reduced, as were the grades of cells positive for TNF-alpha and IL-10 in skin lesions. 15908402 2005
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE In the present study, the anti‑AD effects of a 70% ethanol extract of TAEE were investigated in 2,4‑dinitrochlorobenzene (DNCB)‑treated mice with AD‑like skin lesions and in tumor necrosis factor (TNF)‑α‑ and interferon (IFN)‑γ‑stimulated human keratinocytes (HaCaT cells). 30066901 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 AlteredExpression group BEFREE The effect of CCE on mite antigen-treated NC/Nga mice was evaluated by examining skin symptom severity, levels of serum IgE, tumor necrosis factor-α (TNF-α), and histamine, skin histology, and mRNA expression of cytokines in the skin lesions. 21035532 2011
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 AlteredExpression group BEFREE The mRNA expression in blood and skin lesion for TNF, IFN-γ, IL-1β, IL-6, and IL-17A significantly reduced in patients with ENL after treatment, while mRNA expression for IL-10 and TGF-β was significantly increased both in blood and skin lesion after treatment. 29479352 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 AlteredExpression group BEFREE The expression levels of PGRN and TNF-α were elevated in LSc skin lesions compared with healthy control skin. 30268392 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE Moreover, C5aR1 deficiency significantly decreased IMQ-induced infiltration of plasmacytoid dendritic cells (pDCs), monocytes and neutrophils in psoriatic skin lesions and functions of pDCs, evidenced by the remarkable reduction in the IMQ-induced production of interferon-α (IFN-α) and tumor necrosis factor α (TNF-α), and FMS-like tyrosine kinase 3 ligand (FLT3L)-dependent pDCs differentiation. 31447855 2019
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE Treatment with antibody to TNF-alpha prevented death, resulted in near normal growth, and produced a marked decrease in skin lesions and a profound reduction in the expression of HIV-1 mRNA and gp120. 12388730 2002